Presentation is loading. Please wait.

Presentation is loading. Please wait.

Renal Cell Carcinoma Lung Metastases Surgery: Pathologic Findings and Prognostic Factors  Jalal Assouad, MD, Boriana Petkova, MD, Pascal Berna, MD, Antoine.

Published byGlenna Ratna Gunardi Modified over 5 years ago

Similar presentations

Presentation on theme: "Renal Cell Carcinoma Lung Metastases Surgery: Pathologic Findings and Prognostic Factors  Jalal Assouad, MD, Boriana Petkova, MD, Pascal Berna, MD, Antoine."— Presentation transcript:

1 Renal Cell Carcinoma Lung Metastases Surgery: Pathologic Findings and Prognostic Factors 
Jalal Assouad, MD, Boriana Petkova, MD, Pascal Berna, MD, Antoine Dujon, MD, Christophe Foucault, MD, Marc Riquet, MD, PhD  The Annals of Thoracic Surgery  Volume 84, Issue 4, Pages (October 2007) DOI: /j.athoracsur Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

2 Figure 1 Survival and lung metastases size. Curve 1 is lung metastases less than 20 mm, median, 54 months (n = 37); curve 2 is lung metastases greater than mm, median, 22 months (n = 28). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

3 Figure 2 Survival and lung metastases lymph node involvement. Curve 1 is no involvement, median, 37 months (n = 52); curve 2 is lymph node involvement, median, 14 months (n = 13). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

4 Figure 3 Lung metastases lymph node involvement and corresponding renal cell carcinoma pT. (a) Bilateral lung metastases. (b) Lung metastases and other organ metastasis. (c) Unilateral lung metastases. (DFI = disease-free interval; 5 = subaortic lymph node; 4R and 4L = right and left paratracheal lymph node; N1, N2 = hilar and mediastinal lymph node involvement; 9 = pulmonary ligament lymph node; 7 = subcarinal lymph node; T1a, T1b, T2, T3a, T3b = renal cell carcinoma TNM classification [15]; 3a = phrenic lymph node.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Renal Cell Carcinoma Lung Metastases Surgery: Pathologic Findings and Prognostic Factors  Jalal Assouad, MD, Boriana Petkova, MD, Pascal Berna, MD, Antoine."

Similar presentations

Ricardo L. Oliveira, MD, Moishe Liberman, MD, PhD 

Ricardo L. Oliveira, MD, Moishe Liberman, MD, PhD 
Number of Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer: A Gaussian Curve, Not a Prognostic Factor  Marc Riquet, MD, PhD, Antoine Legras, MD,

Number of Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer: A Gaussian Curve, Not a Prognostic Factor  Marc Riquet, MD, PhD, Antoine Legras, MD,
Thymic Epithelial Tumors: Prognostic Determinants Among Clinical, Histopathologic, and Computed Tomography Findings  Jung Won Moon, MD, Kyung Soo Lee,

Thymic Epithelial Tumors: Prognostic Determinants Among Clinical, Histopathologic, and Computed Tomography Findings  Jung Won Moon, MD, Kyung Soo Lee,
PET, CT, and MRI with Combidex for mediastinal staging in non-small cell lung carcinoma  Kemp H Kernstine, MD, PhD, William Stanford, MD, Brian F Mullan,

PET, CT, and MRI with Combidex for mediastinal staging in non-small cell lung carcinoma  Kemp H Kernstine, MD, PhD, William Stanford, MD, Brian F Mullan,
Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer 

Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer 
History of Multiple Previous Malignancies Should Not Be a Contraindication to the Surgical Resection of Lung Cancer  Pierre-Benoit Pagès, MD, Pierre Mordant,

History of Multiple Previous Malignancies Should Not Be a Contraindication to the Surgical Resection of Lung Cancer  Pierre-Benoit Pagès, MD, Pierre Mordant,
Long-Term Survival of Patients With pN2 Lung Cancer According to the Pattern of Lymphatic Spread  Antoine Legras, MD, Pierre Mordant, MD, PhD, Alex Arame,

Long-Term Survival of Patients With pN2 Lung Cancer According to the Pattern of Lymphatic Spread  Antoine Legras, MD, Pierre Mordant, MD, PhD, Alex Arame,
Masatsugu Hamaji, MD, Stephen D. Cassivi, MD, K

Masatsugu Hamaji, MD, Stephen D. Cassivi, MD, K
Is the Rate of Pneumonectomy Higher in Right Middle Lobe Lung Cancer Than in Other Right-Sided Locations?  Caroline Rivera, MD, Pierre Mordant, MD, PhD,

Is the Rate of Pneumonectomy Higher in Right Middle Lobe Lung Cancer Than in Other Right-Sided Locations?  Caroline Rivera, MD, Pierre Mordant, MD, PhD,
Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non- Small Cell Lung Cancer  Matthew P. Smeltzer, PhD, Nicholas Faris, MDiv,

Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non- Small Cell Lung Cancer  Matthew P. Smeltzer, PhD, Nicholas Faris, MDiv,
Collision Tumor of Esophagus: Report of Three Cases

Collision Tumor of Esophagus: Report of Three Cases
Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Adjuvant Chemotherapy with 5-Fluorouracil and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma  Jeeyun Lee, MD, Kyoung-Eun.

Adjuvant Chemotherapy with 5-Fluorouracil and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma  Jeeyun Lee, MD, Kyoung-Eun.
Number of Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer: A Gaussian Curve, Not a Prognostic Factor  Marc Riquet, MD, PhD, Antoine Legras, MD,

Number of Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer: A Gaussian Curve, Not a Prognostic Factor  Marc Riquet, MD, PhD, Antoine Legras, MD,
Prognostic Factors Associated With Interventional Bronchoscopy in Lung Cancer  Nicolas Guibert, MD, Julien Mazieres, MD, PhD, Benoît Lepage, MD, Gavin.

Prognostic Factors Associated With Interventional Bronchoscopy in Lung Cancer  Nicolas Guibert, MD, Julien Mazieres, MD, PhD, Benoît Lepage, MD, Gavin.
Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer  Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.

Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer  Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.
Francisco J. Ascaso, MD, Jesús M. Castillo, MD, Francisco J

Francisco J. Ascaso, MD, Jesús M. Castillo, MD, Francisco J
Sarcoid-Like Reaction Mimics Progression of Disease After Induction Chemotherapy for Lung Cancer  Masayuki Chida, MD, PhD, Takashi Inoue, MD, Koichi Honma,

Sarcoid-Like Reaction Mimics Progression of Disease After Induction Chemotherapy for Lung Cancer  Masayuki Chida, MD, PhD, Takashi Inoue, MD, Koichi Honma,
Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma  Giulio Melloni, MD, Claudio.

Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma  Giulio Melloni, MD, Claudio.

Similar presentations

Ads by Google